Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer is one of the most aggressive human malignancies, with a very poor prognosis. To evaluate the effect of angiotensin II (Ang II) type 2 receptor (AT<sub>2</sub>) expression in the host's body on the...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-02-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/67 |
id |
doaj-57061e324f6f4e00a5520cbb5995b881 |
---|---|
record_format |
Article |
spelling |
doaj-57061e324f6f4e00a5520cbb5995b8812020-11-25T01:39:17ZengBMCBMC Cancer1471-24072010-02-011016710.1186/1471-2407-10-67Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic miceTroyer DerylIsayama YukaPickel LaraAyuzawa RieUppalapati DeepthiOhta NaomiMaurya DharmendraKawabata AtsushiEgashira NoboruDoi ChiyoTakekoshi SusumuTamura Masaaki<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer is one of the most aggressive human malignancies, with a very poor prognosis. To evaluate the effect of angiotensin II (Ang II) type 2 receptor (AT<sub>2</sub>) expression in the host's body on the growth of pancreatic carcinoma, we have investigated the growth of mouse pancreatic ductal carcinoma grafts in syngeneic wild type and AT<sub>2 </sub>receptor-deficient (AT<sub>2</sub>-KO) mice.</p> <p>Methods</p> <p>The role of AT<sub>2 </sub>receptor-signaling in stromal cells on the growth of murine pancreatic carcinoma cells (PAN02) was studied using various <it>in vitro </it>and <it>in vivo </it>assays. <it>In vivo </it>cell proliferation, apoptosis, and vasculature in tumors were monitored by Ki-67 immunostaining, TUNEL assay, and von Willebrand factor immunostaining, respectively. In the co-culture study, cell proliferation was measured by MTT cell viability assay. All the data were analyzed using t-test and data were treated as significant when <it>p </it>< 0.05.</p> <p>Results</p> <p>Our results show that the growth of subcutaneously transplanted syngeneic xenografts of PAN02 cells, mouse pancreatic ductal carcinoma cells derived from the C57/BL6 strain, was significantly faster in AT<sub>2</sub>-KO mice compared to control wild type mice. Immunohistochemical analysis of tumor tissue revealed significantly more Ki-67 positive cells in xenografts grown in AT<sub>2</sub>-KO mice than in wild type mice. The index of apoptosis is slightly higher in wild type mice than in AT<sub>2</sub>-KO mice as evaluated by TUNEL assay. Tumor vasculature number was significantly higher in AT<sub>2</sub>-KO mice than in wild type mice. <it>In vitro </it>co-culture studies revealed that the growth of PAN02 cells was significantly decreased when grown with AT<sub>2 </sub>receptor gene transfected wild type and AT<sub>2</sub>-KO mouse-derived fibroblasts. Faster tumor growth in AT<sub>2</sub>-KO mice may be associated with higher VEGF production in stromal cells.</p> <p>Conclusions</p> <p>These results suggest that Ang II regulates the growth of pancreatic carcinoma cells through modulating functions of host stromal cells; Moreover, Ang II AT<sub>2 </sub>receptor signaling is a negative regulator in the growth of pancreatic carcinoma cells. These findings indicate that the AT<sub>2 </sub>receptor in stromal fibroblasts is a potentially important target for chemotherapy for pancreatic cancer.</p> http://www.biomedcentral.com/1471-2407/10/67 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Troyer Deryl Isayama Yuka Pickel Lara Ayuzawa Rie Uppalapati Deepthi Ohta Naomi Maurya Dharmendra Kawabata Atsushi Egashira Noboru Doi Chiyo Takekoshi Susumu Tamura Masaaki |
spellingShingle |
Troyer Deryl Isayama Yuka Pickel Lara Ayuzawa Rie Uppalapati Deepthi Ohta Naomi Maurya Dharmendra Kawabata Atsushi Egashira Noboru Doi Chiyo Takekoshi Susumu Tamura Masaaki Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice BMC Cancer |
author_facet |
Troyer Deryl Isayama Yuka Pickel Lara Ayuzawa Rie Uppalapati Deepthi Ohta Naomi Maurya Dharmendra Kawabata Atsushi Egashira Noboru Doi Chiyo Takekoshi Susumu Tamura Masaaki |
author_sort |
Troyer Deryl |
title |
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice |
title_short |
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice |
title_full |
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice |
title_fullStr |
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice |
title_full_unstemmed |
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice |
title_sort |
angiotensin ii type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2010-02-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer is one of the most aggressive human malignancies, with a very poor prognosis. To evaluate the effect of angiotensin II (Ang II) type 2 receptor (AT<sub>2</sub>) expression in the host's body on the growth of pancreatic carcinoma, we have investigated the growth of mouse pancreatic ductal carcinoma grafts in syngeneic wild type and AT<sub>2 </sub>receptor-deficient (AT<sub>2</sub>-KO) mice.</p> <p>Methods</p> <p>The role of AT<sub>2 </sub>receptor-signaling in stromal cells on the growth of murine pancreatic carcinoma cells (PAN02) was studied using various <it>in vitro </it>and <it>in vivo </it>assays. <it>In vivo </it>cell proliferation, apoptosis, and vasculature in tumors were monitored by Ki-67 immunostaining, TUNEL assay, and von Willebrand factor immunostaining, respectively. In the co-culture study, cell proliferation was measured by MTT cell viability assay. All the data were analyzed using t-test and data were treated as significant when <it>p </it>< 0.05.</p> <p>Results</p> <p>Our results show that the growth of subcutaneously transplanted syngeneic xenografts of PAN02 cells, mouse pancreatic ductal carcinoma cells derived from the C57/BL6 strain, was significantly faster in AT<sub>2</sub>-KO mice compared to control wild type mice. Immunohistochemical analysis of tumor tissue revealed significantly more Ki-67 positive cells in xenografts grown in AT<sub>2</sub>-KO mice than in wild type mice. The index of apoptosis is slightly higher in wild type mice than in AT<sub>2</sub>-KO mice as evaluated by TUNEL assay. Tumor vasculature number was significantly higher in AT<sub>2</sub>-KO mice than in wild type mice. <it>In vitro </it>co-culture studies revealed that the growth of PAN02 cells was significantly decreased when grown with AT<sub>2 </sub>receptor gene transfected wild type and AT<sub>2</sub>-KO mouse-derived fibroblasts. Faster tumor growth in AT<sub>2</sub>-KO mice may be associated with higher VEGF production in stromal cells.</p> <p>Conclusions</p> <p>These results suggest that Ang II regulates the growth of pancreatic carcinoma cells through modulating functions of host stromal cells; Moreover, Ang II AT<sub>2 </sub>receptor signaling is a negative regulator in the growth of pancreatic carcinoma cells. These findings indicate that the AT<sub>2 </sub>receptor in stromal fibroblasts is a potentially important target for chemotherapy for pancreatic cancer.</p> |
url |
http://www.biomedcentral.com/1471-2407/10/67 |
work_keys_str_mv |
AT troyerderyl angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT isayamayuka angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT pickellara angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT ayuzawarie angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT uppalapatideepthi angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT ohtanaomi angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT mauryadharmendra angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT kawabataatsushi angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT egashiranoboru angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT doichiyo angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT takekoshisusumu angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice AT tamuramasaaki angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice |
_version_ |
1725049411195633664 |